Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

• Main Authors: Chen R (Author), Wang F (Author), Zhang H (Author), Chen B (Author)
• Formato: Livro
• Publicado em: Dove Medical Press, 2015-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Runzhe Chen, Fei Wang, Hongming Zhang, Baoan ChenDepartment of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of ChinaBackground: Recently, brentuximab vedotin has b...